Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with classical signs and symptoms of Vatarakta. 2. Patients willing to give written informed consent and able to follow treatment and follow- up schedule. 3. Patients with age group of 30 to 70 irrespective of gender,religion and socioeconomic status. 4.Patients with mild to moderate symptoms (not requiring immediate surgical intervention or hospitalization)
Exclusion criteria
Exclusion criteria: 1. Patients with other known inflammatory or degenerative joint diseases like rheumatoid arthritis, septic arthritis, osteoarthritis (severe grade), or connective tissue disorders. 2. History of recent intra-articular injection (within last 4 weeks) in the affected joint. 3. K/C/O Severe systemic illnesses such as uncontrolled diabetes mellitus, uncontrolled hypertension, chronic kidney disease (stage 3 or above), liver dysfunction, or cardiac failure. 4. Patients on long-term systemic steroid therapy or recent use of strong anti-inflammatory drugs. 5. Known allergy or hypersensitivity to any component of Sarivadi Taila or Pinda Taila.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate efficacy of Sarivadi Taila Abhyanga in the management of Vatarakta (Uttana)Timepoint: 7 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To review Vatarakta (Uttana) with special reference to gout according to Ayurvedic and modern perspectives. 2.To review literature related to Sarivadi Taila and the procedure of Abhyanga. 3.To evaluate the efficacy of Pinda Taila Abhyanga in Vatarakta (Uttana) with special reference to gout. 4.To compare the efficacy of Sarivadi Taila Abhyanga with Pinda Taila Abhyanga in Vatarakta (Uttana) with special reference to gout. 5.To observe and record any adverse effects of the drug or procedure, if presentTimepoint: 7 DAYS | — |
Countries
India
Contacts
PMTS AYURVED COLLEGE SHEVGAON